Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Uppsala APP deletion causes early onset autosomal dominant Alzheimer’s disease by altering APP processing and increasing amyloid β fibril formation
María Pagnon de la Vega, Vilmantas Giedraitis, Wojciech Michno, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 606
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Cryo-EM structures of amyloid-β 42 filaments from human brains
Yang Yang, Diana Arseni, Wenjuan Zhang, et al.
Science (2022) Vol. 375, Iss. 6577, pp. 167-172
Open Access | Times Cited: 344
Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
Sjors H. W. Scheres, Benjamin Falcon, Michel Goedert
Nature (2023) Vol. 621, Iss. 7980, pp. 701-710
Closed Access | Times Cited: 109
Hyperoside alleviates toxicity of β-amyloid via endoplasmic reticulum-mitochondrial calcium signal transduction cascade in APP/PS1 double transgenic Alzheimer's disease mice
Linlin Song, Yuan Qu, Yong Tang, et al.
Redox Biology (2023) Vol. 61, pp. 102637-102637
Open Access | Times Cited: 23
Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2
Stefan F. Lichtenthaler, Sarah K. Tschirner, Harald Steiner
Current Opinion in Neurobiology (2021) Vol. 72, pp. 101-110
Closed Access | Times Cited: 44
An atlas of amyloid aggregation: the impact of substitutions, insertions, deletions and truncations on amyloid beta fibril nucleation
Mireia Seuma, Ben Lehner, Benedetta Bolognesi
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer’s Disease
Katja Maria Bendtsen, Vanessa Jane Hall
Cells (2023) Vol. 12, Iss. 3, pp. 420-420
Open Access | Times Cited: 17
Genetic and epigenetic targets of natural dietary compounds as anti-Alzheimer’s agents
Willian Orlando Castillo Ordoñez, Nohelia Cajas‐Salazar, Mayra Alejandra Velasco-Reyes
Neural Regeneration Research (2023) Vol. 19, Iss. 4, pp. 846-854
Open Access | Times Cited: 16
Natural antioxidants that act against Alzheimer’s disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action
Grammatiki Alexandra Sidiropoulou, Athanasios Metaxas, Malamati Kourti
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?
Nobumasa Takasugi, Masato Komai, Nanaka Kaneshiro, et al.
Cells (2023) Vol. 12, Iss. 3, pp. 454-454
Open Access | Times Cited: 15
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease
Leonardo Iaccarino, Jorge J. Llibre‐Guerra, Eric McDade, et al.
Brain Communications (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 5
APP substrate ectodomain defines amyloid‐β peptide length by restraining γ‐secretase processivity and facilitating product release
Matthias Koch, Thomas Enzlein, Shuyu Chen, et al.
The EMBO Journal (2023) Vol. 42, Iss. 23
Open Access | Times Cited: 11
Endogenously generated Dutch-type Aβ nonfibrillar aggregates dysregulate presynaptic neurotransmission in the absence of detectable inflammation
Emilie L. Castranio, Merina Varghese, Elentina K. Argyrousi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Exome Sequencing and Multigene Panel Testing in 1,411 Patients With Adult-Onset Neurologic Disorders
Nika Schuermans, Hannah Verdin, Jody Ghijsels, et al.
Neurology Genetics (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 7
Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
María Pagnon de la Vega, Carl Näslund, RoseMarie Brundin, et al.
BMC Genomics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Expression Changes in Mitochondrial Genes Affecting Mitochondrial Morphology, Transmembrane Potential, Fragmentation, Amyloidosis, and Neuronal Cell Death Found in Brains of Alzheimer’s Disease Patients
Frank J. Castora, Kimberly A. Kerns, Haley K Pflanzer, et al.
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 1, pp. 119-137
Closed Access | Times Cited: 11
BACE1 inhibitors: A promising therapeutic approach for the management of Alzheimer’s disease
Richa Arya, Smita Jain, Sarvesh Paliwal, et al.
Asian Pacific Journal of Tropical Biomedicine (2024) Vol. 14, Iss. 9, pp. 369-381
Open Access | Times Cited: 2
Investigating New Applications of a Photoswitchable Fluorescent Norbornadiene as a Multifunctional Probe for Delineation of Amyloid Plaque Polymorphism
Ambra Dreos, Junyue Ge, Francisco Nájera, et al.
ACS Sensors (2023) Vol. 8, Iss. 4, pp. 1500-1509
Open Access | Times Cited: 5
Interaction of Therapeutic d-Peptides with Aβ42 Monomers, Thermodynamics, and Binding Analysis
Vivian Lorena Leguizamon Herrera, Alexander K. Buell, Dieter Willbold, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 11, pp. 1638-1650
Closed Access | Times Cited: 8
Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling
Katarzyna Marta Zoltowska, Utpal Das, Sam Lismont, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
María Pagnon de la Vega, Stina Syvänen, Vilmantas Giedraitis, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
CNV-Finder: Streamlining Copy Number Variation Discovery
Nicole Kuznetsov, Kensuke Daida, Mary B. Makarious, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Structural reconstruction of individual filaments in Aβ42 fibril populations assembledin vitroreveal rare species that resembleex vivoamyloid polymorphs from human brains
Liam D. Aubrey, Liisa Lutter, Kate Fennell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Potential of fluorescent nanoprobe in diagnosis and treatment of Alzheimer's disease
Jingjing Lin, Hanhan Li, Jingxuan Guo, et al.
Nanomedicine (2022) Vol. 17, Iss. 17, pp. 1191-1211
Closed Access | Times Cited: 5
Alzheimer’s disease linked Aβ42 exerts product feedback inhibition on γ-secretase impairing downstream cell signaling
Katarzyna Marta Zoltowska, Utpal Das, Sam Lismont, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 2
Cryo-EM Structures of Amyloid-β 42 Filaments from Human Brain
Yang Yang, Diana Arseni, Wei Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top